3D-FS33335 - stilbene-44-dicarboxylic-acid
3,3 DIMETHYL CIS 1,2 CYCLOPROPANE DICARBOXYLIC ACID
CAS:Formula:C7H10O4Purezza:98%Colore e forma:SolidPeso molecolare:158.1519cis-1,2-Cyclopropane dicarboxylic acid
CAS:Formula:C5H6O4Purezza:97%Colore e forma:SolidPeso molecolare:130.0987Febuxostat dicarboxylic acid impurity
CAS:Febuxostat dicarboxylic acid impurityPurezza:≥95%Peso molecolare:335.38g/molFebuxostat dicarboxylic acid impurity
CAS:Febuxostat dicarboxylic acid impurity is an impurity of Febuxostat. Febuxostat is selective xanthine oxidase inhibitor with a K i of 0.6 nM [1] .Formula:C16H17NO5SColore e forma:SolidPeso molecolare:335.38Malathion dicarboxylic acid
CAS:Formula:C6H11O6PS2Colore e forma:Colourless CrystallinePeso molecolare:274.25Perfluoropolyether dicarboxylic acid
Perfluoropolyether dicarboxylic acidPurezza:≥95%Colore e forma:LiquidRef: ST-EA-CP-F7010
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaAcetylene dicarboxylic acid potassium salt
CAS:Acetylene dicarboxylic acid potassium salt (ADAC) is a drug that belongs to the class of 2-fluorobenzoic acid derivatives. Acetylene dicarboxylic acid potassium salt inhibits the enzyme 2,3-dihydroxybenzoate-4-hydroxylase and reduces the production of propiolic acid, which leads to a decrease in the synthesis of tetracene. Acetylene dicarboxylic acid potassium salt has been shown to be an effective anesthetic, with good visual and motor activity. The high toxicity of this compound is due to its high affinity for protein binding sites and its ability to form hydrogen bonds.Formula:C4H2KO4Purezza:Min. 95%Peso molecolare:153.15 g/mol2,3-Pyrazine dicarboxylic acid
CAS:Formula:C6H4N2O4Purezza:98%Colore e forma:SolidPeso molecolare:168.1082,3-Pyridine dicarboxylic acid
CAS:Formula:C7H5NO4Purezza:98%Colore e forma:Solid, Light yellow powderPeso molecolare:167.12Bicyclo[2.2.2] octane-1,4 dicarboxylic acid
CAS:Formula:C10H14O4Purezza:97%Colore e forma:SolidPeso molecolare:198.218Bifendate Dicarboxylic Acid
CAS:Prodotto controllatoApplications Carboxylic acid derivative of Bifendate (B382890), a synthetic intermediate of Schisandrin C and also a anti-HBV drug used in the treatment of chronic hepatitis B.
References Pan, S.Y., et al.: Euro. J. Pharmacol. 522, 170 (2006); Zeng, Y., et al.: Acta. Pharmacol. Sinica., 30, 478 (2009);Formula:C18H14O10Colore e forma:NeatPeso molecolare:390.3Cabastine Hydrochloride Dicarboxylic Acid
Prodotto controllatoFormula:C26H31ClFNO4•(HCl)Colore e forma:NeatPeso molecolare:511.169244,5-Disulfo Rhodamine-123 Dicarboxylic Acid Lithium Salt(Mixture of isomers, Technical Grade)
CAS:Prodotto controllatoStability Light Sensitive
Applications 4,5-Disulfo Rhodamine-123 dicarboxylic acid is a xanthene dye substituted two times by a sulfonic acid used as fluorescent probes, particularly in biological samples. It is more photostable than fluorescein.
References Stenman, U., et al.: Cancer Res., 51, 222 (1991), Mitrunen, K., et al.: Clin. Chem., 41, 1115 (1995), Karvinen, J., et al.: Anal. Biochem., 325, 317 (2004), Hemmila, I., et al.: J. Fluoresc., 15, 529 (2005),Formula:C22H16Li2N2O11S2Colore e forma:NeatPeso molecolare:562.37Montelukast dicarboxylic acid
CAS:Prodotto controllatoMontelukast is a drug product that belongs to the class of drugs called leukotriene receptor antagonists. Montelukast binds to cysteinyl leukotrienes (LTC4, LTD4, LTE4) and prevents their interaction with receptors on the cell surface. It can be used for the treatment of asthma, chronic obstructive pulmonary disease, and other allergic conditions. Montelukast is available in tablet form and is taken orally. Montelukast is not expected to be toxic because it has been shown to have a low incidence of side effects in clinical trials.Formula:C35H34ClNO5SPurezza:Min. 95%Peso molecolare:616.20 g/molRef: ST-EA-CP-M25046
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaDimethyl 1,2,3,4-tetrahydronaphthalene-2,6-dicarboxylate
CAS:Formula:Purezza:≥95%Peso molecolare:248.27Ref: BD-BD434832
1gPrezzo su richiesta









